Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ARGENX-SE-16911676/news/argenx-to-Highlight-Potential-First-in-Class-FcRn-Antagonist-Efgartigimod-at-Upcoming-Neuromuscular-36633154/?utm_source=whatsapp&utm_medium=social&utm_campaign=share